Madison.comWhy Crispr Therapeutics AG Stock Bolted Higher in JanuaryMotley FoolA recent study, published ahead of its official peer-review, suggested that CRISPR-Cas9 based therapeutics might be too toxic for use in humans. If true, Crispr, and its fel… Continue reading
|
Immunotherapy in the Treatment of Follicular Lymphoma
OncLive Grzegorz S. Nowakowski, MD: I’d probably start by saying that if you look at follicular lymphoma, this should be the prime target for immunotherapy. We know about the role of the microenvironment in this disease; it has been extensively studied with … |
|
Immunotherapy Drugs Market : Accounting a Higher Growth by 2017–2025
Digital Journal Cancer immunotherapy requires the use of a body’s immune system to fight off cancer. The three types of immunotherapies available are passive, active, and hybrid. The core functionality of immunotherapy revolves around the presence of tissue-associated … |
WWD |
Augustinus Bader Applies Stem Cell Research to New Skin-Care Line
WWD German professor Augustinus Bader has adapted his groundbreaking medical treatment for burn victims into a consumer-facing skin-care brand.This was no small task, according to the expert in regenerative medicine and tissue engineering (who’s also the … |
Tristatehomepage.com |
Immunotherapy future of cancer treatment?
Tristatehomepage.com Around the country, medical researchers have been studying new forms of immune-stimulating cancer treatments, even here in the tri-state. “In the last several years, we’ve worked hard to try to bring some of these trials to deaconess. Currently, we … |
WFLA |
2nd man has gene editing; therapy has no safety flags so far
WFLA (AP) – A second patient has been treated in a historic gene editing study in California, and no major side effects or safety issues have emerged from the first man’s treatment nearly three months ago, doctors revealed Tuesday. Gene editing is a more … |